Heart

Article	Citations
Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis	193
Prevalence, incidence and survival of heart failure: a systematic review	128
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure	101
Atrial fibrillation prevalence, awareness and management in a nationwide survey of adults in China	101
Diagnosis, management and therapeutic strategies for congenital long QT syndrome	96
Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management	93
Monitoring indirect impact of COVID-19 pandemic on services for cardiovascular diseases in the UK	90
Cardiovascular disease and mortality sequelae of COVID-19 in the UK Biobank	80
Excess of cardiovascular deaths during the COVID-19 pandemic in Brazilian capital cities	77
Trends of global burden of atrial fibrillation/flutter from Global Burden of Disease Study 2017	64
Effect of the COVID-19 pandemic on mortality of patients with STEMI: a systematic review and meta-analysis	61
Intensive low-density lipoprotein cholesterol lowering in cardiovascular disease prevention: opportunities and challenges	59
Cardiac sarcoidosis: state-of-the-art review	54
Community prevalence, mechanisms and outcome of mitral or tricuspid regurgitation	54
Arrhythmogenic left ventricular cardiomyopathy	53
Prognostic value of coronary computed tomography angiographic derived fractional flow reserve: a systematic review and meta-analysis	51
Systematic review of current natural language processing methods and applications in cardiology	51
Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry	49
Recreational substance use among patients with premature atherosclerotic cardiovascular disease	48
Sacubitril/valsartan in the treatment of systemic right ventricular failure	44
Artificial intelligence for the echocardiographic assessment of valvular heart disease	43
Efficacy and safety of rilonacept for recurrent pericarditis: results from a phase II clinical trial	43
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis	43
Contrast-enhanced computed tomography assessment of aortic stenosis	43
Cardiotoxicities of novel cancer immunotherapies	41

Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic	40
Cardiac myxomas: clinical presentation, diagnosis and management	39
Association of physical activity trajectories with major cardiovascular diseases in elderly people	38
Parameters associated with ventricular arrhythmias in mitral valve prolapse with significant regurgitation	38
Incidence and outcome of myocardial infarction treated with percutaneous coronary intervention during COVID-19 pandemic	37
Fibrosis, atrial fibrillation and stroke: clinical updates and emerging mechanistic models	36
Lipoprotein(a) is robustly associated with aortic valve calcium	36
The effect of green Mediterranean diet on cardiometabolic risk; a randomised controlled trial	36
Physical activity and the progression of coronary artery calcification	35
Risks and benefits of percutaneous coronary intervention in spontaneous coronary artery dissection	35
Cardiovascular disease risk in immune-mediated inflammatory diseases: recommendations for clinical practice	34
Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease	34
Socioeconomic status and cardiovascular health in the COVID-19 pandemic	33
Greater admissions, mortality and cost of heart failure in adults with congenital heart disease	33
Invasive coronary physiology in patients with angina and non-obstructive coronary artery disease: a consensus document from the coronary microvascular dysfunction workstream of the British Heart Found	32
New insights in diagnostics and therapies in syncope: a novel approach to non-cardiac syncope	31
Bleeding risk with rivaroxaban compared with vitamin K antagonists in patients aged 80 years or older with atrial fibrillation	30
Contrast echocardiography: current status and future directions	30
Effects of salt substitutes on clinical outcomes: a systematic review and meta-analysis	30
Arrhythmogenic right ventricular cardiomyopathy: a focused update on diagnosis and risk stratification	30
Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic	30
Atrial fibrillation: global burdens and global opportunities	29
Metabolic phenotyping and cardiovascular disease: an overview of evidence from epidemiological settings	29
Survival and risk of recurrence of takotsubo syndrome	29
Computed tomography aortic valve calcium scoring for the assessment of aortic stenosis progression	29
Clinical outcome of COVID-19 in patients with adult congenital heart disease	29
Income level and outcomes in patients with heart failure with universal health coverage	28
Association of heart failure and its comorbidities with loss of life expectancy	28
Anticoagulant prescribing for atrial fibrillation and risk of incident dementia	28
Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials	28
Risk of infective endocarditis after surgical and transcatheter aortic valve replacement	27
Primary prevention of cardiovascular disease in women with a Mediterranean diet: systematic review and meta-analysis	27
Ramadan fasting: recommendations for patients with cardiovascular disease	27
MRI and CT coronary angiography in survivors of COVID-19	27
Outcomes and drivers of inappropriate dosing of non-vitamin K antagonist oral anticoagulants (NOACs) in patients with atrial fibrillation: a systematic review and meta-analysis	27
Air pollution and cardiovascular disease: the Paul Wood Lecture, British Cardiovascular Society 2021	27
Effectiveness and safety of oral anticoagulants in elderly patients with atrial fibrillation	27
Epicardial adipose tissue in obesity-related cardiac dysfunction	26
Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction	26
COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction	26
Early clinical and haemodynamic matched comparison of balloon-expandable valves	26
What is the normal composition of pericardial fluid?	26
Association between right ventricular strain and outcomes in patients with dilated cardiomyopathy	26
Heart failure medication dosage and survival in women and men seen at outpatient clinics	25
Endocrine therapy use and cardiovascular risk in postmenopausal breast cancer survivors	25
Getting the best from the Heart Team: guidance for cardiac multidisciplinary meetings	25
Brugada syndrome: update and future perspectives	25
Clinical outcomes in spontaneous coronary artery dissection	25
Transcatheter tricuspid valve replacement in patients with severe tricuspid regurgitation	25
Lipoprotein(a): a risk factor for atherosclerosis and an emerging therapeutic target	24

Contemporary demographics, diagnostics and outcomes in non-bacterial thrombotic endocarditis	24
Quality of life and healthcare utilisation improvements after atrial fibrillation ablation	24
Beta-blockers are associated with better long-term survival in patients with Takotsubo syndrome	24
Aortitis: recent advances, current concepts and future possibilities	24
Socioeconomic disparities in prehospital factors and survival after out-of-hospital cardiac arrest	23
Sexism experienced by consultant cardiologists in the United Kingdom	23
Haemodynamic determinants of improved aerobic capacity after tricuspid valve surgery in Ebstein anomaly	23
Excessive daytime sleepiness: an emerging marker of cardiovascular risk	23
Variations in knowledge, awareness and treatment of hypertension and stroke risk by country income level	23
Pregnancy outcomes in women with aortic coarctation	23
Temporal association between invasive procedures and infective endocarditis	22
Regional variation in cardiovascular magnetic resonance service delivery across the UK	22
Hypereosinophilic syndrome: considerations for the cardiologist	22
Management and outcomes of patients with left atrial appendage thrombus prior to percutaneous closure	22
Impact of sodium-glucose cotransporter-2 inhibitors on heart failure and mortality in patients with cancer	22
Assessment and management of peripheral arterial disease: what every cardiologist should know	21
Cardiogenetics: genetic testing in the diagnosis and management of patients with aortic disease	21
Temporal trends and sex differences in sudden cardiac death in the Copenhagen City Heart Study	21
Association between combat-related traumatic injury and cardiovascular risk	21
Machine learning model for predicting out-of-hospital cardiac arrests using meteorological and chronological data	21
Personalised external aortic root support for elective treatment of aortic root dilation in 200 patients	21
Update on management of atrial fibrillation in heart failure: a focus on ablation	21
Leisure-time and occupational physical activity and health outcomes in cardiovascular disease	20
Prevalence and determinants of atrial fibrillation progression in paroxysmal atrial fibrillation	20
Anti-interleukin 1 agents for the treatment of recurrent pericarditis: a systematic review and meta-analysis	20
Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat	20
MINOCA: a heterogenous group of conditions associated with myocardial damage	20
Cumulative burden of clinically significant aortic stenosis in community-dwelling older adults	20
National Institute for Health and Care Excellence (NICE) guidance on heart valve disease	20
Racial, ethnic and socioeconomic disparities in patients undergoing left atrial appendage closure	20
Considering complexity in the genetic evaluation of dilated cardiomyopathy	20
Analysis of sex differences in the clinical presentation, management and prognosis of infective endocarditis in Spain	19
Smartphone detection of atrial fibrillation using photoplethysmography: a systematic review and meta-analysis	19
Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention	19
Determinants of clinical outcomes of surgery for isolated severe tricuspid regurgitation	19
Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis	19
Absolute coronary flow and microvascular resistance reserve in patients with severe aortic stenosis	19
Vaping and cardiac disease	19
Contribution of NOTCH1 genetic variants to bicuspid aortic valve and other congenital lesions	19
Outcome and durability of mitral valve annuloplasty in atrial secondary mitral regurgitation	19
Left ventricular non-compaction cardiomyopathy: how many needles in the haystack?	19
Discontinuation of oral anticoagulation in atrial fibrillation and risk of ischaemic stroke	19
Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation	19
Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure	19
Management of patients with heart failure and preserved ejection fraction	18
Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care	18
Prognostic impact of cardiac surgery in left-sided infective endocarditis according to risk profile	18
Right ventricular remodelling in pulmonary arterial hypertension predicts treatment response	18
Prediction of short-term atrial fibrillation risk using primary care electronic health records	18
Pregnancy outcomes in women with a systemic right ventricle and transposition of the great arteries results from the ESC-EORP Registry of Pregnancy and Cardiac disease (ROPAC)	18
Diagnostic accuracy of handheld cardiac ultrasound device for assessment of left ventricular structure and function: systematic review and meta-analysis	18
Role of echocardiography in screening and evaluation of athletes	18
Eligibility for early rhythm control in patients with atrial fibrillation in the UK Biobank	18
Standard ECG for differential diagnosis between Anderson-Fabry disease and hypertrophic cardiomyopathy	18
Cardiovascular magnetic resonance imaging: emerging techniques and applications	18
Prognostic value of lower bone mineral density in predicting adverse cardiovascular disease in Asian women	18
Trimethylamine oxide: a potential target for heart failure therapy	18
Infective endocarditis at a tertiary care hospital in South Korea	17
Incident aortic stenosis in 49 449 men and 42 229 women investigated with routine echocardiography	17
Epidemiology of cardiomyopathies and incident heart failure in a population-based cohort study	17
Novel bradycardia pacing strategies	17
Association between age at onset of overweight and risk of hypertension across adulthood	17
Changes in quality of life, cognition and functional status following catheter ablation of atrial fibrillation	17
Effect of blood pressure lowering drugs and antibiotics on abdominal aortic aneurysm growth: a systematic review and meta-analysis	17
National Institute for Health and Care Excellence clinical guidelines development principles and processes	17
Antiplatelet therapy in patients with myocardial infarction without obstructive coronary artery disease	17
Preterm birth and cardiac function in adulthood	16
Comparative effectiveness of oral anticoagulants in everyday practice	16
Mortality and morbidity in patients with congenital heart disease hospitalised for viral pneumonia	16
Nickel hypersensitivity and endovascular devices: a systematic review and meta-analysis	16
Prognostic value of C-reactive protein in adults with congenital heart disease	16
Safety of proprotein convertase subtilisin/kexin 9 inhibitors: a systematic review and meta-analysis	16
Prasugrel versus ticagrelor in patients with myocardial infarction undergoing percutaneous coronary intervention	16
Multiple arterial coronary bypass grafting is associated with greater survival in women	15
Evaluation of antithrombotic use and COVID-19 outcomes in a nationwide atrial fibrillation cohort	15
Cardiovascular or mortality risk of controlled hypertension and importance of physical activity	15
Sex differences in sudden cardiac death in a nationwide study of 54 028 deaths	15
The enigmatic immunoglobulin G4-related disease and its varied cardiovascular manifestations	15
Relative survival after aortic valve surgery in patients with bicuspid aortic valves	15
Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation	15

Safety, efficacy and impact on frailty of mini-invasive radial balloon aortic valvuloplasty	15
N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy	15
Efficacy of treat-and-repair strategy for atrial septal defect with pulmonary arterial hypertension	15
Evaluation of the causes of sex disparity in heart failure trials	14
Mental disorders and cardiovascular disease: what should we be looking out for?	14
Counterpoint: challenges and limitations of transcatheter aortic valve implantation for aortic regurgitation	14
Clinical outcomes of children with rheumatic heart disease	14
Shared decision making in cardiology: a systematic review and meta-analysis	14
Tyrosine kinase inhibitors in chronic myeloid leukaemia and emergent cardiovascular disease	14
Cost-effectiveness of home-based cardiac rehabilitation: a systematic review	14
Cost-effectiveness of transcatheter edge-to-edge repair in secondary mitral regurgitation	14
The new role of diagnostic angiography in coronary physiological assessment	14
Anatomy of the mitral valve relative to controversies concerning the so-called annular disjunction	14
Exercise prescription in individuals with hypertrophic cardiomyopathy: what clinicians need to know	14
Evidence base for the management of women with non-ST elevation acute coronary syndrome	14
Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses	14
Predictors of liver cirrhosis and hepatocellular carcinoma among perioperative survivors of the Fontan operation	14
Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle	14
Hydration for prevention of kidney injury after primary coronary intervention for acute myocardial infarction: a randomised clinical trial	14
Postmenopausal hormone therapy for cardiovascular health: the evolving data	14
Fried-food consumption and risk of cardiovascular disease and all-cause mortality: a meta-analysis of observational studies	14
Nuclear cardiology: state of the art	13
Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden	13
D-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation	13
Frailty and quality of life after invasive management for non-ST elevation acute coronary syndrome	13
Methamphetamine-associated heart failure: a systematic review of observational studies	13
Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes	13
Cohort study of intervened functionally univentricular heart in England and Wales (2000–2018)	13
Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy	13
Clarifying the anatomy of the superior sinus venosus defect	13
Comparisons between biopsy-proven versus clinically diagnosed cardiac sarcoidosis	13
Cardiovascular considerations for scuba divers	13
Improving the diagnosis of heart failure in patients with atrial fibrillation	13
Supraventricular arrhythmia in pregnancy	13
Incident cardiovascular events and imaging phenotypes in UK Biobank participants with past cancer	12
Improving detection and management of familial hypercholesterolaemia in Australian general practice	12
Machine learning-derived electrocardiographic algorithm for the detection of cardiac amyloidosis	12
Antithrombotic therapy for patients with chronic coronary syndromes	12
Association between exercise habit changes and mortality following a cardiovascular event	12
Heightened long-term cardiovascular risks after exacerbation of chronic obstructive pulmonary disease	12
Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004–2018	12
Prognostic implications of left ventricular diastolic dysfunction in moderate aortic stenosis	12
Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction	12
Outcomes and regional differences in practice in a worldwide coronary stent registry	12
Atrial fibrillation following transcatheter atrial septal defect closure: a systematic review and meta-analysis	11
Association between cardiologist evaluation and mortality in myocardial injury after non-cardiac surgery	11
Survival of people with valvular heart disease in a large, English community-based cohort study	11
Pacing induced cardiomyopathy: recognition and management	11
Predictive value of the TRI-SCORE for in-hospital mortality after redo isolated tricuspid valve surgery	11
Use of intracoronary imaging to guide optimal percutaneous coronary intervention procedures and outcomes	11
Race, sex and age disparities in echocardiography among Medicare beneficiaries in an integrated healthcare system	11
Exercise capacity in patients with repaired Tetralogy of Fallot aged 6 to 63 years	11
Bullying in UK cardiology: a systemic problem requiring systemic solutions	11
Prevalence, outcomes and costs of a contemporary, multinational population with heart failure	11
Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II	11
Non-vitamin K antagonist oral anticoagulants, proton pump inhibitors and gastrointestinal bleeds	11
Stroke in patients with secundum atrial septal defect and sequelae after transcatheter closure	11
Optimal diet for cardiovascular and planetary health	11
Pregnancy-related cardiovascular conditions and outcomes in a United States Medicaid population	11
Trends in direct oral anticoagulant (DOAC) prescribing in English primary care (2014–2019)	11
Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19	11
Body mass index and survival in people with heart failure	11
Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1	11
Sex differences in heart failure hospitalisation risk following acute myocardial infarction	11
Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants	11
Premature ventricular complexes and development of heart failure in a community-based population	11
Outcomes in patients with moderate and asymptomatic severe aortic stenosis followed up in heart valve clinics	10
Prospective analysis of gender-related characteristics in relation to cardiovascular disease	10
Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death	10
Socioeconomic characteristics of patients with coronary heart disease in relation to their cardiovascular risk profile	10
Contrasting trends in heart failure incidence in younger and older New Zealanders, 2006–2018	10
Anticoagulation in atrial fibrillation	10
Sex-based differences in atrial fibrillation ablation adverse events	10
Sex differences in investigations and outcomes among patients with type 2 myocardial infarction	10
Aortic dilation and growth in women with Turner syndrome	10
Physical activity and exercise recommendations for patients with valvular heart disease	10
Diagnosis and management of cardiac allograft vasculopathy	10
Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis	10
Medications for specific phenotypes of heart failure with preserved ejection fraction classified by a machine learning-based clustering model	10
Prediction of incident atrial fibrillation in community-based electronic health records: a systematic review with meta-analysis	10
Implementing an early rule-out pathway for acute myocardial infarction in clinical practice	10
Bleeding and thrombotic risk in pregnant women with Fontan physiology	10
Contemporary differences between bicuspid and tricuspid aortic valve in chronic aortic regurgitation	10
Prognostic value of automated longitudinal strain measurements in asymptomatic aortic stenosis	10
Sex difference in atrial fibrillation recurrence after catheter ablation and antiarrhythmic drugs	10
Phenotyping of acute decompensated heart failure with preserved ejection fraction	10
Newly diagnosed diabetes and outcomes after acute myocardial infarction in young adults	10
Supplemental calcium and vitamin D and long-term mortality in aortic stenosis	10
Translational applications of computational modelling for patients with cardiac arrhythmias	10
Patient values and preferences on valve replacement for aortic stenosis: a systematic review	10
Socioeconomic position and cardiovascular mortality in 63 million adults from Brazil	9
Multimodality imaging for the diagnosis of infiltrative cardiomyopathies	9
Electrocardiographic biomarkers to predict atrial fibrillation in sinus rhythm electrocardiograms	9
Aspirin and statin therapy for primary prevention of cardiovascular disease in older adults	9
Left atrial phasic function: physiology, clinical assessment and prognostic value	9